TopNews

Washington D.C. [USA], Oct. 5 : An interdisciplinary team of engineers and pharmaceutical researchers at the University of Alberta has invented a device that can rapidly identify harmful bacteria and can determine whether it is resistant to antibiotics.

The device could save precious hours in patient care and public health, and prevent the spread of drug-resistant strains of bacteria.

The team's findings can help in detecting bacteria and measure their susceptibility to antibiotics in small confined volumes.

The device was designed to look for and trap different types of bacteria and find out which antibiotics are most effective against them.

Rather than growing bacterial cultures then testing them, the microscopic device relies on nano-scale technology for fast results.

Washington D.C. [USA], Oct. 5 : A recent research has found that Botox (a bladder injection of botulinum toxin) could help in controlling bladder incontinence, after the first and second-line therapies proved inadequate.

A head-to-head comparison of sacral neuromodulation that (an implanted device sold as InterStim), or and botulinum toxin shows that Botox provides more daily relief for women, but might also be associated with more adverse events.

Botox in the bladder muscle works to address urgency urinary incontinence by relaxing the overactive bladder muscles that cause the condition.

A sacral neuromodulation implant does the same thing by sending electrical pulses to nerves in the spine.

New Delhi [India], Oct.5 : Hotelogix, the leading global property management systems (PMS) provider, announced its India expansion plans and mobile strategy to cater to specific requirements of the Indian hospitality industry. Hotelogix today announced the launch of its most advanced property management solution (PMS) to enable small and mid-market independent hotels and chains, to leverage mobile for their entire front desk and housekeeping operations.

Washington D.C. [USA], Oct. 5 : A couple of Kanye West's concerts in Saint Pablo have been rescheduled following the recent break in at wife, Kim Kardashian's hotel room in Paris.

According to a statement, the rapper has rescheduled two upcoming shows that were originally scheduled for October 4 and 6, for his ongoing Saint Pablo Tour to December 13 and 22, reports E! Online.

"Due to family concerns, this week's Philadelphia and Detroit dates on the Saint Pablo Tour have been rescheduled," Live Nation said in a statement, "The Philadelphia show will take place on December 13 and the Detroit show on December 22."

The rapper had reportedly cancelled his New York City concert mid-show to protect his wife, who was held at gunpoint and robbed of millions of dollars worth of jewelry.

Washington D.C. [USA], Oct. 5 : A recent research could pave the way to end tobacco cravings after researchers crystallized a protein that holds answers to how nicotine addiction occurs in the brain.

The breakthrough at the Peter O'Donnell comes after decades of failed attempts to crystallize and determine the 3D structure of a protein that will help scientists to develop new treatments by understanding nicotine's molecular effects.

Co-author Ryan Hibbs said, "It's going to require a huge team of people and a pharmaceutical company to study the protein and develop the drugs, but I think this is the first major stepping stone to making that happen."

The protein, called the a4ß2 (alpha-4-beta-2) nicotinic receptor, sits on nerve cells in the brain.

Washington D.C. [USA], Oct. 5 : A new study gives greater insight into the growth of cancer cells, bringing researchers one step closer to the fight against the fatal disease.

The study identifies a previously unknown "off-switch" for cancer, based on the protein TMX1, that can serve as a new strategy for personalized medicine.

Cancer tissue is known to alter its metabolic behaviour by repressing respiration.

This metabolic switch accelerates growth of tumour cells and promotes resistance to cell death mechanisms, making cancer difficult to treat.

The study found that the reduction of the protein TMX1 can single-handedly exacerbate these characteristics of cancer cells.